Hyperbaric oxygenation (HBOT ) continues to be a significantly effective adjunctive treatment in breast cancer management, offering benefits such as enhanced wound healing, reduced risks of radiation damage and bolstered immune function.
Irish Life Health takes the lead in paying for HBOT at OxyGeneration to reduce risks of complications arising from plastic surgery. Post breast surgery complications, such as failed or compromised skin grafts and flaps, are often attributed to poor blood flow and inadequate oxygen supply to the affected tissues. HBOT leads to significantly higher oxygen levels in the bloodstream which promotes angiogenesis (the formation of new blood vessels ) and enhances the delivery of oxygen to damaged tissues, facilitating the healing process and reducing the likelihood of complications post-surgery.
The same rationale extends to the application of HBOT for non-healing wounds. Introducing HBOT is helping people to achieve enhanced healing outcomes post surgery meaning the requirement for re-operation is significantly reduced. Those at risk of these complications are urged to discuss HBOT with their doctor.
HBOT also helps to minimise radiation-induced damage by improving tissue oxygenation, leading to better outcomes for patients undergoing radiation therapy. Additionally, HBOT boosts immune function, crucial in cancer treatment where compromised immunity leaves patients vulnerable. By enhancing white blood cell activity and stimulating tissue repair, HBOT contributes to overall wellness and resilience during treatment.
OxyGeneration, a leading provider of hyperbaric oxygenation, recognises the importance of supporting research initiatives aimed at advancing breast cancer treatment. As a sponsor of the National Breast Cancer Research Institute’s upcoming masquerade ball, OxyGeneration is committed to contributing to the ongoing efforts of the breast cancer research team at the Lambe Institute in Galway. For more information contact OxyGeneration on 091 394444 or email [email protected].
